Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The **microbial pathogen membrane** refers collectively to the cell membranes of pathogenic microorganisms such as bacteria. It is a lipid bilayer composed primarily of phospholipids and proteins, with gram-negative bacteria possessing both inner and outer membranes, while gram-positive bacteria have a single cytoplasmic membrane and thick cell wall. Microbial membranes act as barriers controlling the selective passage of substances, maintaining ion gradients, and facilitating cellular processes such as respiration and synthesis of cellular components. They serve as targets for several classes of antibiotics and antimicrobial peptides, which disrupt membrane integrity or inhibit its biosynthesis to induce cell death. These membranes are topologically and compositionally distinct from eukaryotic membranes, but the term "microbial pathogen membranes" does not refer to a specific molecule, receptor, or protein but rather to a broad and heterogeneous class of structures found in a wide range of microbes[2][3][5][8]. Notably, as a **therapeutic target**, "microbial pathogen membranes" is imprecise; it refers to a structure rather than a single molecular entity. The broad targeting of membranes underlies the non-specific action of some drugs and toxicity concerns, as well as the rapid evolution of microbial resistance through changes in membrane composition[1][5]. This is not a singular, canonical molecular target. The designation is overly broad for chemical indexing, drug screening, and structural biology purposes. Accordingly, the entry is **scientifically imprecise and would require further specification (e.g., “lipid II,” “outer membrane protein A,” “cardiolipin synthase”) for structured databases or drug targeting contexts**.
Membrane disruption; Pore formation; Inhibition of biosynthesis; Increased permeability leading to cell lysis; Inhibition of membrane-bound enzymes
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial pathogen membrane.